n(g),n(g')-dimethyl-l-arginine has been researched along with Cirrhosis, Liver in 10 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
| Excerpt | Relevance | Reference |
|---|---|---|
| "Asymmetric dimethylarginine (ADMA) is an inhibitor of nitric oxide synthase that accumulates in liver disease and may contribute to hepatic encephalopathy (HE)." | 3.79 | Asymmetric dimethylarginine is strongly associated with cognitive dysfunction and brain MR spectroscopic abnormalities in cirrhosis. ( Ahluwalia, V; Bajaj, JS; Bouneva, I; Fuchs, M; Gilles, H; Heuman, DM; Kraft, KA; Luketic, V; Monteith, P; Noble, NA; Puri, P; Sanyal, AJ; Sterling, RK; Stravitz, RT; Wade, JB; White, MB, 2013) |
| "To assess the hepatic clearance of bacterial products in individuals with cirrhosis, we tested concentrations of Gram-negative bacterial lipopolysaccharide (LPS), LPS-binding protein (LBP), and the precursor of nitric oxide (NO), L-arginine, in a cohort of 8 stable patients with liver cirrhosis before and after elective transjugular portosystemic shunt (TIPS) implantation, including central venous, hepatic venous, and portal venous measurements." | 3.77 | The transhepatic endotoxin gradient is present despite liver cirrhosis and is attenuated after transjugular portosystemic shunt (TIPS). ( Balagopal, A; Benten, D; Böger, RH; Buggisch, P; Franco, V; Gaydos, CA; Koops, A; Lohse, AW; Ray, SC; Schulze zur Wiesch, J; Sydow, K; Won, H, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eisinger, K | 1 |
| Krautbauer, S | 1 |
| Wiest, R | 2 |
| Karrasch, T | 1 |
| Hader, Y | 1 |
| Scherer, MN | 1 |
| Farkas, S | 1 |
| Aslanidis, C | 1 |
| Buechler, C | 1 |
| Sheen, JM | 1 |
| Chen, YC | 1 |
| Tain, YL | 1 |
| Huang, LT | 1 |
| Rolla, R | 1 |
| Vidali, M | 1 |
| Sartori, M | 1 |
| Andorno, S | 1 |
| Pagliarulo, M | 1 |
| Carmagnola, S | 1 |
| Ballaré, M | 1 |
| Orsello, M | 1 |
| Montino, F | 1 |
| Anderloni, A | 1 |
| Suno, A | 1 |
| Del Piano, M | 1 |
| Bellomo, G | 1 |
| Pilz, S | 1 |
| Putz-Bankuti, C | 1 |
| Meinitzer, A | 1 |
| März, W | 1 |
| Kienreich, K | 1 |
| Stojakovic, T | 1 |
| Pieber, TR | 1 |
| Stauber, RE | 1 |
| Lluch, P | 1 |
| Segarra, G | 1 |
| Medina, P | 1 |
| Siroen, MP | 1 |
| Richir, MC | 1 |
| Teerlink, T | 1 |
| Rauwerda, JA | 1 |
| Drescher, FT | 1 |
| Zorger, N | 1 |
| van Leeuwen, PA | 1 |
| Benten, D | 1 |
| Schulze zur Wiesch, J | 1 |
| Sydow, K | 1 |
| Koops, A | 1 |
| Buggisch, P | 1 |
| Böger, RH | 1 |
| Gaydos, CA | 1 |
| Won, H | 1 |
| Franco, V | 1 |
| Lohse, AW | 1 |
| Ray, SC | 1 |
| Balagopal, A | 1 |
| Bajaj, JS | 1 |
| Ahluwalia, V | 1 |
| Wade, JB | 1 |
| Sanyal, AJ | 1 |
| White, MB | 1 |
| Noble, NA | 1 |
| Monteith, P | 1 |
| Fuchs, M | 1 |
| Sterling, RK | 1 |
| Luketic, V | 1 |
| Bouneva, I | 1 |
| Stravitz, RT | 1 |
| Puri, P | 1 |
| Kraft, KA | 1 |
| Gilles, H | 1 |
| Heuman, DM | 1 |
| Vizzutti, F | 1 |
| Romanelli, RG | 1 |
| Arena, U | 1 |
| Rega, L | 1 |
| Brogi, M | 1 |
| Calabresi, C | 1 |
| Masini, E | 1 |
| Tarquini, R | 1 |
| Zipoli, M | 1 |
| Boddi, V | 1 |
| Marra, F | 1 |
| Laffi, G | 1 |
| Pinzani, M | 1 |
| Mookerjee, RP | 1 |
| Jalan, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Dexamethasone Implant on Retinal Nerve Fiber and Optic Disc Morphology in Patients With Diabetic Maculopathy[NCT03927118] | 43 participants (Actual) | Observational | 2018-02-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for n(g),n(g')-dimethyl-l-arginine and Cirrhosis, Liver
| Article | Year |
|---|---|
Increased circulatory asymmetric dimethylarginine and multiple organ failure: bile duct ligation in rat as a model.
Topics: Animals; Arginine; Bile Ducts; Disease Models, Animal; Fibrosis; Ligation; Liver; Liver Cirrhosis; M | 2014 |
Asymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosis.
Topics: Amidohydrolases; Animals; Arginine; Hemodynamics; Humans; Hypertension, Portal; Liver; Liver Cirrhos | 2015 |
8 other studies available for n(g),n(g')-dimethyl-l-arginine and Cirrhosis, Liver
| Article | Year |
|---|---|
Portal vein omentin is increased in patients with liver cirrhosis but is not associated with complications of portal hypertension.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Ascites; Case-Control Studies; Cytokines; Enzyme-Linked Im | 2013 |
Does asymmetric dimethylarginine (ADMA) plasma concentration predict esophageal varices in patients with cirrhosis?
Topics: Aged; Arginine; Biomarkers; Esophageal and Gastric Varices; Female; Humans; Liver Cirrhosis; Male; M | 2014 |
Association of homoarginine and methylarginines with liver dysfunction and mortality in chronic liver disease.
Topics: Adult; Aged; Arginine; Chronic Disease; Disease-Free Survival; Female; Follow-Up Studies; Homoargini | 2015 |
Transjugular intrahepatic portosystemic shunt-placement increases arginine/asymmetric dimethylarginine ratio in cirrhotic patients.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Female; Follow-Up Studies; Humans; Hypertension, Portal; L | 2008 |
The transhepatic endotoxin gradient is present despite liver cirrhosis and is attenuated after transjugular portosystemic shunt (TIPS).
Topics: Acute-Phase Proteins; Adult; Aged; Arginine; Bacterial Translocation; Carrier Proteins; Cohort Studi | 2011 |
Asymmetric dimethylarginine is strongly associated with cognitive dysfunction and brain MR spectroscopic abnormalities in cirrhosis.
Topics: Adult; Arginine; Aspartic Acid; Biomarkers; Brain; Cognition Disorders; Cross-Sectional Studies; Fem | 2013 |
ADMA correlates with portal pressure in patients with compensated cirrhosis.
Topics: Adult; Aged; Arginine; Case-Control Studies; Female; Hepatitis C, Chronic; Humans; Hypertension, Por | 2007 |
ADMA correlates with portal pressure in patients with compensated cirrhosis by Vizzutti et al. Eur J Clin Invest 2007; 37: 509-15.
Topics: Arginine; Humans; Liver Cirrhosis; Nitric Oxide; Portal Pressure | 2008 |